Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | MBTPS1 | Q14703 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CTSS | P25774 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
| ▸ | CTSK | P43235 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | TACR1 | P25103 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | MMP14 | P50281 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | KLK7 | P49862 | 1/20 | 0.42 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3365449 | 0.99 | ACE (0.51) | ACEFOLH1MBTPS1POLBCTSS | |
| SCHEMBL19853660 | 0.89 | ACE (0.52) | ACEFOLH1MBTPS1POLBCTSS | |
| SCHEMBL10825244 | 0.86 | ACE (0.67) | ACEMBTPS1POLBTACR1MMP2 | |
| SCHEMBL20322999 | 0.83 | ACE (0.51) | ACEMBTPS1POLBTACR1 | |
| Hydrochloric Acid SCHEMBL3019993 | 0.83 | ACE (0.51) | ACEMBTPS1POLBTACR1MMP9 | |
| SCHEMBL10825301 | 0.83 | ACE (0.51) | ACEMBTPS1POLBTACR1 | |
| SCHEMBL19401695 | 0.83 | ACE (0.51) | ACEMBTPS1POLBTACR1 | |
| SCHEMBL20804457 | 0.80 | PPARA (0.53) | FOLH1CTSSCTSLCTSKPPARA | |
| Hydrochloric Acid SCHEMBL28303273 | 0.79 | ITGB3 (0.52) | CTSSCTSLCTSKTACR1 | |
| SCHEMBL20804450 | 0.77 | FOLH1 (0.49) | FOLH1CTSSCTSLCTSKPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140142167-A1 | Micellar Preparation Containing Sparingly Water-Soluble Anticancer Agent And Novel Block Copolymer | NANOCARRIER KABUSHIKI KAISHA (JP) | 2014-05-22 | — | — | US | disclosed |
| US-7820759-B2 | Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-10-26 | — | — | US | disclosed |
| EP-1604687-B1 | MICELLAR PREPARATION CONTAINING SPARINGLY WATER-SOLUBLE ANTICANCER AGENT AND NOVEL BLOCK COPOLYMER | NIPPON KAYAKU KK (JP) | 2010-10-06 | — | — | EP | disclosed |
| CN-1761485-B | Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer | NIPPON KAYAKU KK | 2010-04-28 | — | — | CN | disclosed |
| US-20090156742-A1 | Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer | NANOCARRIER KABUSHIKI KAISHA (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20060099265-A1 | Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer | NANOCARRIER KABUSHIKI KAISHA (JP) | 2006-05-11 | — | — | US | disclosed |
| CN-1761485-A | Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer | NIPPON KAYAKU KK (JP) | 2006-04-19 | — | — | CN | disclosed |
| EP-1604687-A1 | MICELLAR PREPARATION CONTAINING SPARINGLY WATER-SOLUBLE ANTICANCER AGENT AND NOVEL BLOCK COPOLYMER | Nippon Kayaku Kabushiki Kaisha (JP) | 2005-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142167-A1 | Micellar Preparation Containing Sparingly Water-Soluble Anticancer Agent And Novel Block Copolymer | FLT1, NGLY1, CXCR1 | ACE 3119/4885FOLH1 1983/4885MBTPS1 703/4885 |
| US-20060099265-A1 | Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer | FLT1, NGLY1, SLC7A1 | ACE 3248/4885FOLH1 2338/4885MBTPS1 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.